The author would like to update “Conflicts of Interest” section of their previous publication [1] as follows:
Conflicts of Interest
Georges Brousse has received sponsorship to attend scientific meetings, speaker honoraria, and consultancy fees from Lundbeck and Merck-Lipha. Patrick Bendimerad received honoraria and travel reimbursements for conferences and consultancy by Lundbeck Laboratory and participated as a coinvestigator.in the multicenter investigational drug studies of Lundbeck. Ingrid de Chazeron received honoraria for consultancy by Lundbeck Laboratory. Pierre Michel Llorca received honoraria and travel reimbursements for conferences by Lundbeck Laboratory. Pascal Perney received honoraria and travel reimbursements for conferences and consultancy by Merck/Serono and Lundbeck Laboratories, and participated as a coinvestigator in the multicenter investigational drug studies of Ethypharm (baclofen), Lundbeck (nalmefene) and D&A Pharma (GHB, sodium oxybate) Laboratories. Maurice Dematteis received honoraria and travel reimbursements for conferences by Merck/Serono and Lundbeck Laboratories, honoraria for consultancy by Lundbeck Laboratory, and participated as a coinvestigator in the multicenter investigational drug studies (ALPADIR, ALPADE for baclofen) of Ethypharm Laboratory.
Reference
- 1.Brousse G., Bendimerad P., de Chazeron I., Llorca P.M., Perney P., Dematteis M. Alcohol risk reduction in France: A modernised approach related to alcohol misuse disorders. Int. J. Environ. Res. Public Health. 2014;11:11664–11675. doi: 10.3390/ijerph111111664. [DOI] [PMC free article] [PubMed] [Google Scholar]